As we plan for an economy coming out of the pandemic the Canadian isotope sector can be an important sector for the recovery. In order to ensure that Canadians benefit from recent advances in nuclear medicine, Canada can build and maintain a domestic supply of both established and emerging medical isotopes, and strengthen our ability to commercialize isotopes into clinical-quality products.
This event will examine the Canadian isotope landscape in the wake of COVID 19, the current uses and applications of isotopes, demonstrate the economic impact of Canadian leadership in isotope production and explore the necessary policy steps to ensure that Canada remains an isotope superpower.
GUESTS:
James Scongack
Executive Vice-President, Corporate Affairs & Operational Services,
Bruce Power
Kathryn Hayshi
President and CEO,
TRIUMF Innovations
Richard Wiens
Director of Strategic Supply & Marketing, Nordion
Rebecca Wong
Staff Radiation Oncologist, Princess Margaret Hospital/University Health Network
Paul Lefebvre (MP)
Parliamentary Secretary to the Minister of Natural Resources
RECORDED: Dec. 3 2020

